Paul Leber

1.2k total citations
22 papers, 882 citations indexed

About

Paul Leber is a scholar working on Economics and Econometrics, Cognitive Neuroscience and Physiology. According to data from OpenAlex, Paul Leber has authored 22 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Economics and Econometrics, 5 papers in Cognitive Neuroscience and 4 papers in Physiology. Recurrent topics in Paul Leber's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Pain Management and Placebo Effect (4 papers) and Treatment of Major Depression (3 papers). Paul Leber is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Pain Management and Placebo Effect (4 papers) and Treatment of Major Depression (3 papers). Paul Leber collaborates with scholars based in United States. Paul Leber's co-authors include Harvey M. Levy, Elizabeth M. Ryan, Charles S. Davis, Stanley Cohen, Shun Shimohama, L. J. Thal, Martin L. Milgrom, Christopher Silber, Angelico Carta and Rachelle S. Doody and has published in prestigious journals such as Journal of Biological Chemistry, Biological Psychiatry and Epilepsia.

In The Last Decade

Paul Leber

22 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Leber United States	12	312	184	146	126	102	22	882
Anuradha Ramamoorthy United States	19	319 1.0×	62 0.3×	106 0.7×	429 3.4×	41 0.4×	49	1.3k
László Tóthfalusi Hungary	25	306 1.0×	115 0.6×	65 0.4×	132 1.0×	107 1.0×	83	1.5k
D. Hadler Germany	9	210 0.7×	111 0.6×	177 1.2×	133 1.1×	30 0.3×	19	584
Carsten Hofmann Switzerland	17	356 1.1×	213 1.2×	623 4.3×	481 3.8×	34 0.3×	43	1.3k
Dewei Shang China	17	416 1.3×	230 1.3×	71 0.5×	154 1.2×	23 0.2×	83	1.2k
Alessandra Bizzarro Italy	18	216 0.7×	204 1.1×	349 2.4×	154 1.2×	64 0.6×	40	886
Olivier Rabin United States	16	201 0.6×	65 0.4×	111 0.8×	89 0.7×	23 0.2×	34	951
Rita Florio Italy	16	230 0.7×	29 0.2×	106 0.7×	176 1.4×	24 0.2×	28	792
R.A. Voskuyl Netherlands	12	434 1.4×	223 1.2×	186 1.3×	64 0.5×	105 1.0×	18	1.1k
D. Garceau Canada	15	330 1.1×	138 0.8×	661 4.5×	349 2.8×	19 0.2×	35	1.1k

Countries citing papers authored by Paul Leber

Since Specialization

Citations

This map shows the geographic impact of Paul Leber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Leber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Leber more than expected).

Fields of papers citing papers by Paul Leber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Leber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Leber. The network helps show where Paul Leber may publish in the future.

Co-authorship network of co-authors of Paul Leber

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Leber. A scholar is included among the top collaborators of Paul Leber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Leber. Paul Leber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laska, Eugene, Craig Mallinckrodt, Paul Leber, et al.. (2009). Assessing Onset of Treatment Benefit in Depression and Anxiety. The Journal of Clinical Psychiatry. 70(8). 1138–1145. 2 indexed citations

Laska, Eugene & Paul Leber. (2002). If Placebo Works, Could, Should or Would it be Approved for Marketing?. CHANCE. 15(2). 22–26. 1 indexed citations

Leber, Paul. (2000). The use of placebo control groups in the assessment of psychiatric drugs: an historical context. Biological Psychiatry. 47(8). 699–706. 33 indexed citations

Leber, Paul & Charles S. Davis. (1998). Threats to the Validity of Clinical Trials Employing Enrichment Strategies for Sample Selection. Controlled Clinical Trials. 19(2). 178–187. 68 indexed citations

Thal, L. J., Angelico Carta, Rachelle S. Doody, et al.. (1997). Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.. PubMed. 11 Suppl 3. 46–9. 25 indexed citations

Bodick, N., F. Forette, D. Hadler, et al.. (1997). Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group.. PubMed. 11 Suppl 3. 50–3. 28 indexed citations

Leber, Paul. (1997). Slowing the progression of Alzheimer disease: methodologic issues.. PubMed. 11 Suppl 5. S10–21; discussion S37. 75 indexed citations

Leber, Paul. (1996). Observations and Suggestions on Antidementia Drug Development. Alzheimer Disease & Associated Disorders. 10(Supplement 1). 31–35. 58 indexed citations

Leber, Paul. (1996). Challenges to the ethicality of clinical research.. PubMed. 32(1). 11–3. 6 indexed citations

10.

Leber, Paul. (1994). Psychotherapeutic Medications Development Program (PMDP) Workshop on NMDA Receptor Antagonists: neurotoxicity evaluation. Introduction.. PubMed. 30(4). 527–32. 2 indexed citations

11.

Leber, Paul. (1991). Is there an alternative to the randomized controlled trial?. PubMed. 27(1). 3–8. 21 indexed citations

12.

Leber, Paul. (1990). British Association for Psychopharmacology Max Hamilton Memorial Lecture Quantitative estimates of drug effects in psychopharmacology: what we measure and what we do not. Journal of Psychopharmacology. 4(2). 53–62. 3 indexed citations

13.

Leber, Paul. (1989). Hazards of Inference: The Active Control Investigation. Epilepsia. 30(s1). S57–63; discussion S64. 95 indexed citations

14.

Leber, Paul. (1986). The placebo control in clinical trials (a view from the FDA).. PubMed. 22(1). 30–2. 23 indexed citations

15.

Leber, Paul. (1983). Adverse drug reactions--vital statistics (unavailable, yet essential).. PubMed. 19(2). 254–7. 1 indexed citations

16.

Leber, Paul. (1982). Adverse drug reactions. Safe passage (how good a guarantee?).. PubMed. 18(4). 6–10. 13 indexed citations

17.

Leber, Paul. (1981). Lithium leukocytosis, and leukemia: the probable influence of biologic plausibility on clinical concern.. PubMed. 17(2). 10–3. 6 indexed citations

18.

Leber, Paul. (1981). Sudden death as a risk of neuroleptic treatment: (a continuing controversy).. PubMed. 17(3). 6–9. 5 indexed citations

19.

Leber, Paul, Martin L. Milgrom, & Stanley Cohen. (1973). Eosinophils in Delayed Hypersensitivity Skin Reaction Sites. Immunological Communications. 2(6). 615–620. 15 indexed citations

20.

Levy, Harvey M., Paul Leber, & Elizabeth M. Ryan. (1963). Inactivation of Myosin by 2,4-Dinitrophenol and Protection by Adenosine Triphosphate and Other Phosphate Compounds. Journal of Biological Chemistry. 238(11). 3654–3659. 391 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact